enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. RNA-binding protein - Wikipedia

    en.wikipedia.org/wiki/RNA-binding_protein

    RNA-binding proteins (often abbreviated as RBPs) ... (CNV), for example CNV gains of BYSL in colorectal cancer cells [19] and ESRP1, CELF3 in breast cancer, ...

  3. RNA-targeting small molecule drugs - Wikipedia

    en.wikipedia.org/wiki/RNA-targeting_small...

    Recent discoveries implicating RNA in the pathogenesis of several forms of cancer and neuromuscular diseases have created a paradigm shift in drug discovery.This work combined with advances in structural characterization techniques such as NMR spectroscopy, X-ray crystallography, Cryogenic electron microscopy [1] together with computational modeling, [2] has pushed forward the realization that ...

  4. RNA therapeutics - Wikipedia

    en.wikipedia.org/wiki/RNA_Therapeutics

    RNA aptamers can be designed to act as antagonists, agonists, or so-called ”RNA decoy aptamers." [87] [102] In the case of antagonists, the RNA aptamer is used either to prevent binding of a certain protein to its cell membrane receptor or to prevent the protein from performing its activity by binding to the protein's target. [87]

  5. List of antineoplastic agents - Wikipedia

    en.wikipedia.org/wiki/List_of_antineoplastic_agents

    Melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal junction (GEJ) cancer.

  6. Antisense therapy - Wikipedia

    en.wikipedia.org/wiki/Antisense_therapy

    Antisense therapy is a form of treatment that uses antisense oligonucleotides (ASOs) to target messenger RNA (mRNA). ASOs are capable of altering mRNA expression through a variety of mechanisms, including ribonuclease H mediated decay of the pre-mRNA, direct steric blockage, and exon content modulation through splicing site binding on pre-mRNA. [1]

  7. Aptamer - Wikipedia

    en.wikipedia.org/wiki/Aptamer

    The DD, AD, DA, and AA letters mean that they have different combinations of unnatural base pairs. This causes their difference in binding strengths. The "-" columns have no protein, and the "+" columns do have protein. Aptamer with protein (+) and without protein (-) is loaded into wells in a gel and moves down the column lanes.

  8. RBM3 - Wikipedia

    en.wikipedia.org/wiki/RBM3

    100043257 Ensembl ENSG00000102317 n/a UniProt P98179 n/a RefSeq (mRNA) NM_001017430 NM_001017431 NM_006743 XM_036156140 RefSeq (protein) NP_006734 n/a Location (UCSC) Chr X: 48.57 – 48.58 Mb n/a PubMed search Wikidata View/Edit Human View/Edit Mouse Putative RNA-binding protein 3 is a protein that in humans is encoded by the RBM3 gene. Function This gene is a member of the glycine -rich RNA ...

  9. DDX3X - Wikipedia

    en.wikipedia.org/wiki/DDX3X

    DEAD box proteins are putative RNA helicases characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD). They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution ...